SCHOOL OF EDUCATION AND HEALTH

Transcription

1 SCHOOL OF EDUCATION AND HEALTH MASTER IN ATHLETIC TRAINING AND THERAPY SYLLABUS PHARMACOLOGY IN SPORT

2 1. IDENTIFICATION DATA OF THE SUBJECT. Title: School: Department: Module: Course Name: Master in Athletic Training and Therapy Education and Health Physiotherapy Required Training Pharmacology in Sport Code: School Year: Semester: Course type (basic, required or optional): 2nd 1 st Required ECTS credits: 3 Teaching method: Language: Webpage: On-site Spanish/English 2. PREREQUISITES. Mandatory: None Recommended: None 3. COURSE CONTRIBUTIONS TO THE CURRICULUM. Course field. Health Sciences Interdisciplinary relationship with other courses of the curriculum. The topics presented in this course are the foundation of all other subjects in the curriculum. Course contributions to the curriculum and profession. Health promotion, the prevention and treatment of disease and the improvement of quality of life requires professional athletic trainers to have adequate training in all subjects related to pharmacology and the knowledge to apply it as a therapeutic tool. Continued studies in pharmacological advances and health topics will allow athletic trainers to develop the expert and quality skills that today's society demands. The knowledge acquired with this subject will also allow the student to establish the proper basis of care necessary to contribute to the restoration of health. Within this scope of practice is the administration of specific drugs and observation of the patient, including recognition of both the therapeutic response and the possible adverse effects. 4. LEARNING OBJECTIVES: COMPETENCIES THAT THE COURSE DEVELOPS 1

3 COMPETENCIES, INSTRUCTIONAL AND EVALUATION METHODS COMPETENCIES PHP-48. Explain the known usage patterns, general effects, and short- and long-term adverse effects for the commonly used dietary supplements, performance enhancing drugs, and recreational drugs. PHP-49. Identify which therapeutic drugs, supplements, and performance-enhancing substances are banned by sport and/or workplace organizations in order to properly advise clients/patients about possible disqualification and other consequences. TI-21. Explain the federal, state, and local laws, regulations and procedures for the proper storage, disposal, transportation, dispensing (administering where appropriate), and documentation associated with commonly used prescription and nonprescription medications. TI-22. Identify and use appropriate pharmaceutical terminology for management of medications, inventory control, and reporting of pharmacological agents commonly used in an athletic training facility. TI-23. Use an electronic drug resource to locate and identify indications, contraindications, precautions, and adverse reactions for common prescription and nonprescription medications. TI-24. Explain the major concepts of pharmacokinetics and the influence that exercise might have on these processes. TI-25. Explain the concepts related to bioavailability, half-life, and bioequivalence (including the relationship between generic and brand name drugs) and their relevance to the patient, the choice of medication, and the dosing schedule. TI-26. Explain the pharmacodynamic principles of receptor theory, dose-response relationship, placebo effect, potency, and drug interactions as they relate to the mechanism of drug action and therapeutic effectiveness. TI-27. Describe the common routes used to administer medications and their advantages and disadvantages. TI-28. Properly assist and/or instruct the patient in the proper use, cleaning, and storage of drugs commonly delivered by metered dose inhalers, nebulizers, insulin pumps, or other parenteral routes as prescribed by the physician. TI-29. Describe how common pharmacological agents influence pain and healing and their influence on various therapeutic interventions. TI-30. Explain the general therapeutic strategy, including drug categories used for treatment, desired treatment outcomes, and typical duration of treatment, for the following common diseases and conditions: asthma, diabetes, hypertension, infections, depression, GERD, allergies, pain, inflammation, and the common cold. TI-31. Optimize therapeutic outcomes by communicating with patients and/or appropriate healthcare professionals regarding compliance issues, drug interactions, adverse drug reactions, and sub-optimal therapy. INSTRUCTIONAL METHOD 1. Assignments (worksheets, written assignments, digital assignments, projects, powerpoint, etc) 2. Lecture with discussion 3. Small group discussion or Class discussion EVALUATION METHOD 2

4 Individual Graded 1. Written Exam/Quiz Group Graded 2. Group Work and Cooperative Learning LEARNING OBJECTIVES RELATED TO THE COMPETENCES 1. Students will be able to describe the behavior and functional evolution of drugs from the moment they are administered until they are eliminated from the body. 2. Students will be able to describe the basic pharmacological characteristics of the principle therapeutic drugs for various conditions and their mechanisms of action. 3. Students will acquire and use the appropriate pharmacological terminology and expressions in the clinical setting. 4. Students can identify the indications, purpose, pharmacological interactions, adverse effects and drug intoxication levels for each medication as well as perform a benefit-risk analysis. 5. Students recognize and know how to correctly manage the medications they will administer, their presentation forms, routes, proper dosage and administration intervals. 6. Students will know how to relate certain physiological, pathological and interindividual variables can affect the action of drugs. 7. Students will correctly interpret and apply the pharmacological prescription made by the doctor, following the administration guidelines to obtain an optimal therapeutic response. 8. Students will be able to confidently inform the patient about the treatment they will receive and the techniques and procedures to be performed. 9. Students will be able to locate pertinent information regarding the medications that must be handled and administered to various patients in a clinical setting. 10. As healthcare providers, students will be practitioners of Spanish Health System standards governing pharmacological methods and vigilance. 11. Students will be active participants in the health education of the general population, especially on the proper use of medication and on efforts promote safety and rational use. 3

5 5. CONTENTS / AGENDA / DIDACTIC UNITS - General concepts in Pharmacology - Drug forms and routes of drug administration - Basic principles of pharmacokinetics - Basic principles of pharmacodynamics - Adverse effects of drugs - Drug interactions - Pathophysiology of pain and analgesic, antipyretic and anti-inflammatory drugs o Central analgesics opioids - Pathophysiology of gout and hypouricemic and anti-gout drugs - Pharmacology of the autonomic nervous system (ANS) o Cholinergic and adrenergic transmission - Pharmacology of the skeletal muscle o Muscle relaxants - Local and general anesthetic drugs - Pathophysiology of epilepsy o Antiepileptic and anticonvulsive drugs - Cardiac pathophysiology and pharmacology o Positive inotropic drugs o Antianginals and antiarrhythmics - Physiopathology of hypertension o Antihypertensive drugs - Pathophysiology of dyslipidemias o Lipid-lowering drugs (antihyperlipidemic) - Pharmacology of hemostasis and coagulation - Pathophysiology and pharmacotherapy of anemia - Pathophysiology of diabetes o Insulin and non-insulin antidiabetics - Doping control and banned substances - Sport supplementation 6. SCHEDULE UNITS/LESSONS SEMINAR 1 TIME SPAN OCTOBER 4

6 5

7 7. BIBLIOGRAPHY Bibliography Rang HP, Dale MM, Ritter JM, Moore PK. Farmacología, 6a edición. Madrid: Elsevier; Zabalegui A, Mangues I. Administración de medicamentos y de dosis. Barcelona: Elsevier, Mendoza N. Farmacología Médica. Madrid: Panamericana, 2008 Mycek MJ. Farmacología. Madrid: McGraw-Hill-Interamericana,